by Danielle Medeiros | Apr 9, 2020 | Thinking Out Loud -Blog
Through the Futuroscope The COVID-19 crisis has frozen time, and yet, there will be a future beyond COVID. What will life be like in 4 months? 6 months? A year? Can we imagine that future? It’s hard, but yes, a new day will come, and progress is...
by Danielle Medeiros | Apr 7, 2020 | Events, Thinking Out Loud -Blog, Webinars
This webinar has passed. You may watch the recorded recap here. We invite you to join us on May 15, 2020 for “Immune Engineering Human B cell-Derived Antibodies for Emerging Infectious Diseases” Please extend this invitation to any colleagues or associates...
by Danielle Medeiros | Mar 27, 2020 | Events, Featured, Thinking Out Loud -Blog
Team EpiVax remains hard at work through this global health crisis. Our scientists are dedicated to the cause while navigating new office protocols. Our fearless leaders Annie De Groot and Bill Martin remain on site at our Olneyville office, along with other key...
by Danielle Medeiros | Mar 16, 2020 | Thinking Out Loud -Blog
22 Years of Preparation for this Coronavirus Moment Infectious Disease experts and vaccinologists? Not usually your favorite person at the cocktail party, but then, we didn’t have Coronavirus, right? To be honest, it’s nice that my neighbors are stopping...
by Danielle Medeiros | Feb 6, 2020 | Thinking Out Loud -Blog
UPDATE March 4, 2020: We’re working as fast as we can. Currently, the EpiVax Vaccine Team (Lenny Moise, Annie De Groot, Christine Boyle, and Lauren Meyers) are designing vaccines for four different efforts – Peptide-based vaccines (Press release HERE); A Spike-based...
by Danielle Medeiros | Oct 23, 2019 | Featured, News, Thinking Out Loud -Blog
Announced today, Chugai Pharmaceutical Co., Ltd. (“Chugai”), a member of the Roche Group, will extend the company’s licensed access to the Immunogenicity Screening and Protein Reengineering Interface (ISPRI) toolkit developed by EpiVax, Inc....
